The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Prodrug-based intracellular delivery of anticancer agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,174
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Self-citationBae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0789 · Cited by 1,247
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., Rejniak, S. X., Gordon, K. A., DeBlanc, R., Toki, B. E., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0039 · Cited by 931
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
WOLINSKY, J., & GRINSTAFF, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.012 · Cited by 540
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
Padilla De Jesús, O. L., Ihre, H. R., Gagne, L., Fréchet, J. M. J., & Szoka, F. C. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010103m · Cited by 507
Kovtun, Y. V., Audette, C. A., Ye, Y., Xie, H., Ruberti, M. F., Phinney, S. J., Leece, B. A., Chittenden, T., Blättler, W. A., & Goldmacher, V. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3973 · Cited by 479
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Kowal, R. C., Herz, J., Weisgraber, K. H., Mahley, R. W., Brown, M. S., & Goldstein, J. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87014-4 · Cited by 445
Bae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.017 · Cited by 444
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, E., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 441
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Designing dendrimers for drug delivery
Liu, M., & Fréchet, J. M. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00203-5 · Cited by 434
Hyaluronan catabolism: a new metabolic pathway
Stern, R. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00392 · Cited by 427
Potent antibody drug conjugates for cancer therapy
Senter, P. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.023 · Cited by 401
The role of glutathione in detoxication
Ketterer, B., Coles, B., & Meyer, D. J. (1983) · Environmental Health Perspectives · doi:10.1289/ehp.834959 · Cited by 396
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., & Nowotnik, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.07.009 · Cited by 392
Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.020 · Cited by 377
Clathrin-dependent endocytosis
MOUSAVI, S. A., MALERØD, L., BERG, T., & KJEKEN, R. (2004) · Biochemical Journal · doi:10.1042/bj20031000 · Cited by 375
DiJoseph, J. F., Armellino, D. C., Boghaert, E. R., Khandke, K., Dougher, M. M., Sridharan, L., Kunz, A., Hamann, P. R., Gorovits, B., Udata, C., et al. (2004) · Blood · doi:10.1182/blood-2003-07-2466 · Cited by 361
Greenwald, R. B. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00331-5 · Cited by 353
Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis
Liaudet-Coopman, E., Beaujouin, M., Derocq, D., Garcia, M., Glondu-Lassis, M., Laurent-Matha, V., Prébois, C., Rochefort, H., & Vignon, F. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.007 · Cited by 351
A novel connector linkage applicable in prodrug design
Carl, P. L., Chakravarty, P. K., & Katzenellenbogen, J. A. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00137a001 · Cited by 351
Squalenoyl Nanomedicines as Potential Therapeutics
Couvreur, P., Stella, B., Reddy, L. H., Hillaireau, H., Dubernet, C., Desmaële, D., Lepêtre-Mouelhi, S., Rocco, F., Dereuddre-Bosquet, N., Clayette, P., et al. (2006) · Nano Letters · doi:10.1021/nl061942q · Cited by 329
Self-citationTargeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Prodrug strategies in cancer therapy
Denny, W. A. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01253-3 · Cited by 290
Lysosomes: A laboratory handbook
Dingle, J. T. (1972) · Medical Entomology and Zoology · Cited by 280
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis
Hua, Q., Knudson, C. B., & Knudson, W. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.1.365 · Cited by 278
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
Schally, A., & Nagy, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410001 · Cited by 271
Nanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Immunoconjugates containing novel maytansinoids: promising anticancer drugs.
CHARI, R. V. J., Martell, B., Gross, J. L., Cook, S., Shah, S. A., Blättler, W. A., McKenzie, S. J., & Goldmacher, V. S. (1992) · PubMed · Cited by 266
Rejmanová, P., Kopeček, J., Pohl, J., Baudyš, M., & Kostka, V. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841006 · Cited by 264
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Luo, Y., Ziebell, M. R., & Prestwich, G. D. (2000) · Biomacromolecules · doi:10.1021/bm000283n · Cited by 261
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1989) · PubMed · Cited by 258
Immordino, M. L., Brusa, P., Rocco, F., Arpicco, S., Ceruti, M., & Cattel, L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.001 · Cited by 251
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers
El-Sayed, M., Ginski, M., Rhodes, C., & Ghandehari, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00087-1 · Cited by 251
Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50713-4 · Cited by 246
Trouet, A., Masquelier, M., Baurain, R., & Deprez-De Campeneere, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.2.626 · Cited by 233
Hamann, P. R., Hinman, L. M., Beyer, C. F., Lindh, D., Upeslacis, J., Flowers, D. A., & Bernstein, I. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0100206 · Cited by 230
Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells
Firestone, R. A. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00026a002 · Cited by 225
Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions
Savić, R., Eisenberg, A., & Maysinger, D. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600874538 · Cited by 218
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
Omelyanenko, V, Kopečková, P., Gentry, C., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00235-6 · Cited by 216
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Tolcher, A. W., Ochoa, L., Hammond, L. A., Patnaik, A., Edwards, T., Takimoto, C., Smith, L., de Bono, J., Schwartz, G., Mays, T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.137 · Cited by 206
Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M., Brown, A. N. F., Watson, G., Knyba, R. E., Wawrzynczak, E. J., & Blakey, D. C. (1987) · PubMed · Cited by 204
Minko, T., Kope?kov�, P., & Kope?ek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<108::aid-ijc17>3.0.co;2-8 · Cited by 198
Saleh, M. N., Sugarman, S., Murray, J., Ostroff, J. B., Healey, D., Jones, D., Daniel, C. R., LeBherz, D., Brewer, H., Onetto, N., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2282 · Cited by 196
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.
Liu, C., Tadayoni, B. M., Bourret, L. A., Mattocks, K. M., Derr, S. M., Widdison, W. C., Kedersha, N. L., Ariniello, P. D., Goldmacher, V. S., Lambert, J. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8618 · Cited by 196
Kono, K., Kojima, C., Hayashi, N., Nishisaka, E., Kiura, K., Watarai, S., & Harada, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.017 · Cited by 192
Chemotherapy targeted to cancers through tumoral hormone receptors
Schally, A. V., & Nagy, A. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.07.002 · Cited by 184
Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses
Pelkmans, L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.06.009 · Cited by 181
Ojima, I., Slater, J. C., Michaud, E., Kuduk, S. D., Bounaud, P.-Y., Vrignaud, P., Bissery, M.-C., Veith, J. M., Pera, P., & Bernacki, R. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9604080 · Cited by 165
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
Auzenne, E., Ghosh, S. C., Khodadadian, M., Rivera, B., Farquhar, D., Price, R. E., Ravoori, M., Kundra, V., Freedman, R. S., & Klostergaard, J. (2007) · Neoplasia · doi:10.1593/neo.07229 · Cited by 159
Controlled biodegradability of polymers — a key to drug delivery systems
Kopec̆ek, J. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90062-0 · Cited by 155
Prodrugs : challenges and rewards
Stella, V. J. (2007) · Cited by 153
Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Jerger, K., Macaraeg, N., & Szoka, F. C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9001206 · Cited by 150
Nagy, A., Schally, A. V., Halmos, G., Armatis, P. E., Cai, R., CSERNUS, V. J., Kovács, M., Koppán, M., Szepesházi, K., & Kahán, Z. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1794 · Cited by 146
Role of Plasma Lipoproteins in Modifying the Biological Activity of Hydrophobic Drugs
Wasan, K. M., & Cassidy, S. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970407a · Cited by 146
Nori, A., Jensen, K. D., Tijerina, M., Kopečková, P., & Kopec̆ek, J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255900 · Cited by 145
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
Okarvi, S. M. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.07.017 · Cited by 145
Reddy, L. H., Dubernet, C., Lepêtre‐Mouelhi, S., Marque, P. E., Desmaële, D., & Couvreur, P. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.018 · Cited by 143
Self-citationShiah, J.-G., Dvořák, M., Kopečková, P., Sun, Y., Peterson, C. M., & Kopec̆ek, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00374-9 · Cited by 140
Altaner, Č. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.023 · Cited by 138
King, D., Dubowchik, G. M., Mastalerz, H. A., Willner, D., Hofstead, S. J., Firestone, R. A., Lasch, S. J., & Trail, P. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020149g · Cited by 135
Rowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
Couvreur, P., Reddy, L. H., Mangenot, S., Poupaert, J. H., Desmaële, D., Lepêtre‐Mouelhi, S., Pili, B., Bourgaux, C., Amenitsch, H. W., & Ollivon, M. (2008) · Small · doi:10.1002/smll.200700731 · Cited by 131
Self-citationBissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Conover, C. D., Greenwald, R. B., Pendri, A., Gilbert, C. W., & Shum, K. L. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050837 · Cited by 122
Minko, T., Kopečková, P., & Kopeček, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018959029186 · Cited by 121
Minko, T., Paranjpe, P. V., Qiu, B., Lalloo, A., Won, R., Stein, S., & Sinko, P. J. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0463-1 · Cited by 120
Prodrug Strategies Based on Intramolecular Cyclization Reactions
Shan, D., Nicolaou, M. G., Borchardt, R. T., & Wang, B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970069d · Cited by 117
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Yu, D., Peng, P., Dharap, S. S., Wang, Y., Mehlig, M., Chandna, P., Zhao, H., Filpula, D. R., Yang, K., Borowski, V., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.050 · Cited by 116
Tumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
Coradini, D., Pellizzaro, C., Miglierini, G., Daidone, M. G., & Perbellini, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f · Cited by 114
Greenwald, R. B., Pendri, A., Conover, C. D., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990166e · Cited by 110
Greenwald, R. B., Choe, Y. H., Conover, C. D., Shum, K. L., Wu, D., & Royzen, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990498j · Cited by 107
The crucial role of spacer groups in macromolecular prodrug design
Soyez, H., Schacht, E. H., & Vanderkerken, S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00400-0 · Cited by 107
Rosato, A., Banzato, A., Luca, G. D., Renier, D., Bettella, F., Pagano, C., Esposito, G., Zanovello, P., & Bassi, P. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.08.020 · Cited by 102
Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cells
Guilbaud, N., Gas, N., Dupont, M.-A., & Valette, A. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450122 · Cited by 99
Bildstein, L., Dubernet, C., Marsaud, V., Chacun, H., Nicolas, V., Gueutin, C., Sarasin, A. R., Bénech, H., Lepêtre‐Mouelhi, S., Desmaële, D., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.120 · Cited by 97
Self-citationReddy, L. H., Khoury, H., Paci, A., Deroussent, A., Ferreira, H. J., Dubernet, C., Declèves, X., Besnard, M., Chacun, H., Lepêtre‐Mouelhi, S., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020735 · Cited by 97
Self-citationTherapeutic applications of aptamers
Kaur, G., & Roy, I. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.43 · Cited by 95
Self‐immolative dendrimers as novel drug delivery platforms
Shabat, D. (2006) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.21258 · Cited by 92
Review of recent studies on resistance to cytotoxic deoxynucleoside analogues
Jordheim, L. P., & Dumontet, C. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.004 · Cited by 92
Omelyanenko, V. G., Kopečková, P., Gentry, C. A., Shiah, J.-G., & Kopec̆ek, J. (1996) · Journal of drug targeting · doi:10.3109/10611869608996827 · Cited by 91
Dosio, F., Reddy, L. H., Ferrero, A., Stella, B., Cattel, L., & Couvreur, P. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100154g · Cited by 90
Self-citationBergman, A. M., Kuiper, C. M., Voorn, D. A., Comijn, E. M., Myhren, F., Sandvold, M. L., Hendriks, H. R., & Peters, G. J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.028 · Cited by 85
Akima, K., Ito, H., Iwata, Y., et al. (1996) · Journal of drug targeting · doi:10.3109/10611869609046255 · Cited by 78
Reddy, L. H., Renoir, J., Marsaud, V., Lepêtre‐Mouelhi, S., Desmaële, D., & Couvreur, P. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900099e · Cited by 74
Self-citationHamann, P. R., Hinman, L. M., Beyer, C. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049795f · Cited by 74
Breistøl, K., Balzarini, J. M., Sandvold, M. L., Myhren, F., Martinsen, M., Clercq, E. D., & Fodstad, Ø. (1999) · PubMed · Cited by 70
Antitumoral Activity of Liposomes and Immunoliposomes Containing 5-Fluorouridine Prodrugs
Crosasso, P., Brusa, P., Dosio, F., Arpicco, S., Pacchioni, D., Schuberî, F., & Cattel, L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9604467 · Cited by 70
Boghaert, E. R., Sridharan, L., Armellino, D. C., Khandke, K. M., DiJoseph, J. F., Kunz, A., Dougher, M. M., Jiang, F., Kalyandrug, L. B., Hamann, P. R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0037 · Cited by 66
Antibody-Directed Enzyme Prodrug Therapy
Bagshawe, K. D. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427050-00004 · Cited by 53
Wang, B., Gangwar, S., Pauletti, G. M., Siahaan, T. J., & Borchardt, R. T. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo961778z · Cited by 52
Koning, G. A., Kamps, J. A. A. M., & Scherphof, G. L. (2002) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(02)00087-9 · Cited by 52
Murakami, Y., Tabata, Y., & Ikada, Y. (1997) · Drug Delivery · doi:10.3109/10717549709033184 · Cited by 51
Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages
Dubowchik, G. M., Radia, S., Mastalerz, H. A., Walker, M. A., Firestone, R. A., King, D., Hofstead, S. J., Willner, D., Lasch, S. J., & Trail, P. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00194-4 · Cited by 51
Choi, W.-M., Kopečková, P., Minko, T., et al. (1999) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159901400601 · Cited by 49
Development of new derivatives of primaquine by association with lysosomotropic carriers.
Trouet, A., Pirson, P., Steiger, R. F., Masquelier, M., Baurain, R., & Gillet, J. (1981) · Europe PMC (PubMed Central) · Cited by 43
Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats.
Worrell, N. R., Cumber, A. J., Parnell, G. D., Mirza, A., Forrester, J. A., & Ross, W. C. J. (1986) · PubMed · Cited by 43
Interaction of a new anticancer prodrug, gemcitabine–squalene, with a model membrane
Pili, B., Bourgaux, C., Amenitsch, H. W., Keller, G., Lepêtre‐Mouelhi, S., Desmaële, D., Couvreur, P., & Ollivon, M. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.04.011 · Cited by 40
Self-citationCP‐4055 and CP‐4126 are active in ara‐C and gemcitabine‐resistant lymphoma cell lines
Galmarini, C. M., Myhren, F., & Sandvold, M. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07467.x · Cited by 39
Versluis, A., Rensen, P. C. N., Rump, E. T., van Berkel, T. J. C., & Bijsterbosch, M. K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.730 · Cited by 39
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
Rodon, J. A., Garrison, M. A., Hammond, L. A., Bono, J. S. D., Smith, L. S., Forero, L., Hao, D., Takimoto, C. H. M., Lambert, J. M., Pandite, L. N., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0672-8 · Cited by 37
Miyamoto, Y., Oda, T., & Maeda, H. (1990) · PubMed · Cited by 37
Koning, G. A., Gorter, A., Scherphof, G. L., & Kamps, J. A. A. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690588 · Cited by 35
Searle, F., Gac-Breton, S., Keane, R., Dimitrijević, S., Brocchini, S., Sausville, E. A., & Duncan, R. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001544 · Cited by 33
Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies
Bildstein, L., Marsaud, V., Chacun, H., Lepêtre‐Mouelhi, S., Desmaële, D., Couvreur, P., & Dubernet, C. (2010) · Soft Matter · doi:10.1039/c0sm00342e · Cited by 32
Self-citationThe biochemistry of lipoproteins
Salter, A. M., & Brindley, D. N. (1988) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800566 · Cited by 30
Koller-Lucae, S. K. M., Schott, H. N., & Schwendener, R. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690558 · Cited by 29
Macromolecular Prodrugs of Small Molecules
Marinaro, W. A., & Stella, V. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-49785-3_27 · Cited by 9
Monoclonal Antibody Drug Conjugates for Cancer Therapy
Senter, P. D., & Meyer, D. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3_14 · Cited by 8
Proteolysis of xyotax by lysosomal cathepsin B; metabolic profiling in tumor cells using LC-MS
(2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)81079-6 · Cited by 8
Targeting - Cancer — Small Molecules
de Groot, V. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3_13 · Cited by 4
(1989) · PubMed
Cited by
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery
Li, Y., Maciel, D., Rodrigues, J., Shi, X., & Tomás, H. (2015) · Chemical Reviews · doi:10.1021/cr500131f · Cited by 478
Small conjugate-based theranostic agents: an encouraging approach for cancer therapy
Kumar, R., Shin, W. S., Sunwoo, K., Kim, W. Y., Koo, S., Bhuniya, S., & Kim, J. S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00224a · Cited by 381
Ramasamy, T., Ruttala, H. B., Gupta, B., Poudel, B. K., Choi, H.-G., Yong, C. S., & Kim, J. O. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.043 · Cited by 373
Metadata
- Authors
- Bildstein, L., Dubernet, C., & Couvreur, P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 63
- Issue
- 1-2
- Pages
- 3-23
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2082943688
- Cited by
- 310
- References
- 136
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.